Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the treatment of peripheral T-cell lymphoma after underwhelming monotherapy data. Peripheral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback